Mumps Virus Replication Cycle: Step-by-Step Molecular Mechanism

The mumps virus (MuV), a member of the Paramyxoviridae family, replicates exclusively in the cytoplasm of infected host cells. Below is the sequential replication cycle.

1. Attachment

The viral hemagglutinin-neuraminidase (HN) glycoprotein binds sialic acid receptors on host cell surfaces (respiratory epithelium, salivary gland ducts). HN also possesses neuraminidase activity, cleaving sialic acids to prevent self-aggregation and facilitate release.

2. Fusion & Entry

The fusion (F) glycoprotein undergoes conformational change, mediating fusion of the viral envelope with the host plasma membrane at neutral pH. The nucleocapsid (genomic RNA + N, P, L proteins) is released into the cytoplasm.

3. Transcription

  • The viral RNA-dependent RNA polymerase (RdRp, L-P complex) transcribes the negative-sense genome into 7–8 monocistronic, capped, polyadenylated mRNAs.
  • Transcription follows a gradient: genes near the 3′ leader (N, P, M, F, SH, HN, L) are transcribed more abundantly.

4. Translation

Host ribosomes translate viral mRNAs into structural proteins (N, P, M, F, SH, HN, L) and non-structural proteins (V, W, I from P gene editing) that modulate interferon responses.

5. Genome Replication

  • RdRp synthesizes a full-length positive-sense antigenome (template for new genomes).
  • Encapsidation of nascent RNA by N protein is concurrent with synthesis (N-RNA complex).
  • Antigenome serves as template for progeny negative-sense genomes.

6. Assembly

  • Matrix (M) protein orchestrates assembly: binds nucleocapsids, interacts with cytoplasmic tails of F and HN at the plasma membrane, and drives budding.
  • SH (small hydrophobic) protein may modulate host apoptosis and membrane curvature.

7. Budding & Release

Progeny virions bud from the plasma membrane, acquiring their envelope with embedded F and HN spikes. Release is non-lytic—cells survive initially, allowing sustained production and cell-to-cell spread.

Immune Evasion Highlights

  • V protein blocks STAT1/2 nuclear translocation → inhibits IFN-α/β and IFN-γ signaling.
  • SH protein inhibits TNF-α-mediated apoptosis and NF-κB activation.

Understanding this cycle informs antiviral targets (e.g., F protein fusion inhibitors, RdRp inhibitors) and vaccine design (live-attenuated Jeryl Lynn strain).

Viral Infections - Related Articles